Global and China Antihypertensive Drugs Industry 2016 Deep Market Research Report
- QYR605988
- 136 Pages
- June 2016
- Pharmaceuticals
This report studies Antihypertensive Drugs in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Antihypertensive Drugs in North America, Japan, Europe, India, Southeast Asia and China, forecast to 2020, from 2015.
Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Diuretics
Calcium channel blockers (CCB)
ACE inhibitors (ACE-I)
Angiotensin II receptor antagonists (ARB)
Adrenergic receptor antagonists
Vasodilators
Benzodiazepines
Renin Inhibitors
Aldosterone receptor antagonists
Alpha-2 adrenergic receptor agonists
Split by manufacturers, this report focuses on the sales, price of each type, average price of Antihypertensive Drugs, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Pfizer
Norvatis
Merck
Sanofi
Daiichi-Sankyo
Boehringer-Ingelheim
Bayer
AstraZeneca
GSK
Bristol-Myers Squibb
Tekeda
Shihuida Pharm (China)
Second Pharmaceutical (China)
Yangtze River Pharmaceutical(China)
Hengrui Medicine(China)
Qilu Pharmaceutical(China)
HUALON (China)
Dawnrays(China)
HISUN Pharmceutical(China)
Split by regions, this report focuses on the sales (consumption), production, import and export of Antihypertensive Drugs in North America, Japan, Europe, India and China, from 2011 to 2020 (forecast), covering
North America
Europe
Japan
China
India
Southeast Asia
Split by applications, this report focuses on consumption and growth rate of @@@@ in major applications.
Split by applications, covering
Primary hypertension
Secondary hypertension
With 136 pages, 168 charts and eight chapters, to display the market present situation and future, clearly and deeply.
Global and China Antihypertensive Drugs Research Report to 2020
1 Antihypertensive Drugs Overview and Each Type
1.1 Product Overview of Antihypertensive Drugs
1.1.1 Definition and Product Scope of Antihypertensive Drugs
1.1.2 Global Market Size (Value and Volume) of Antihypertensive Drugs 2015-2020
1.1.3 China Market Size (Value and Volume) of Antihypertensive Drugs 2015-2020
1.2 Classification of Antihypertensive Drugs
1.2.1 Diuretics
1.2.1.1 Loop diuretics
1.2.1.2 Thiazide diuretics
1.2.1.3 Thiazide-like diuretics
1.2.1.4 Potassium-sparing diuretics
1.2.2 Calcium channel blockers (CCB)
1.2.2.1 Dihydropyridines
1.2.2.2 Dihydropyridines
1.2.3 ACE inhibitors (ACE-I)
1.2.4 Angiotensin II receptor antagonists (ARB)
1.2.5 Adrenergic receptor antagonists
1.2.5.1 Beta blockers
1.2.5.2 Alpha blockers
1.2.5.3 Mixed Alpha+ Beta blockers
1.2.6 Vasodilators
1.2.7 Benzodiazepines
1.2.8 Renin Inhibitors
1.2.9 Aldosterone receptor antagonists
1.2.10 Alpha-2 adrenergic receptor agonists
1.2.11 Market Share and Growth Rate of Each Type
1.3 Key Manufactures and price of Each Type in 2015 and 2016
1.3.1 Key Manufactures of each Type
1.3.2 Price List (Interviewed) of Main Types by Key Manufacturers
1.3.2.1 ARB
1.3.2.2 CCB
1.3.2.3 ACE-I
2 Competition Analysis by Manufacturers in Global and China
2.1 Global Market Antihypertensive Drugs Sales and Share List of Key Manufacturers 2015 to 2016
2.2 Global Market Antihypertensive Drugs Revenue and Share List of Key Manufacturers 2015 to 2016
2.3 Global Antihypertensive Drugs Average Price List of Key Manufacturers 2015 to 2016
2.4 China Market Antihypertensive Drugs Sales and Share List of Key Manufacturers 2015 to 2016
2.5 China Market Antihypertensive Drugs Revenue and Share List of Key Manufacturers 2015 to 2016
2.6 China Antihypertensive Drugs Average Price List of Key Manufacturers 2015 to 2016
3 Sales and Revenue Segments of Each Type 2015 to 2016
3.1 Global Sales and Revenue Segments of Each Type 2015 to 2016
3.1.1 Global Sales and Market Share of Each Type 2015 to 2016
3.1.2 Global Revenue and Market Share of Each Type 2015 to 2016
3.3 ACE-I Sales and Growth Rate 2015 to 2020
3.4 ARB Sales and Growth Rate 2015 to 2020
3.5 Adrenergic Receptor Antagonists Sales and Growth Rate 2015 to 2020
3.6 Other Types Sales and Growth Rate 2015 to 2020
4 Market Segments and Forecast of Antihypertensive Drugs by Regions
4.1 Sales (Consumption) and Forecast of Antihypertensive Drugs by Regions 2015-2020
4.1.1 Sales and Forecast of Antihypertensive Drugs by Regions 2015-2020
4.1.2 Sales Growth Rate Forecast of Antihypertensive Drugs by Regions 2015 to 2020
4.2 Production and Forecast of Antihypertensive Drugs by Regions 2015 to 2020
4.2.1 Production and Forecast of Antihypertensive Drugs by Regions 2015 to 2020
4.2.2 Production Growth Rate Forecast of Antihypertensive Drugs by Regions 2015 to 2020
4.3 North America Market Forecast to 2020
4.3.1 North America Sales (Consumption), Production, Import and Export of Antihypertensive Drugs 2015 to 2020
4.4 Europe Market Forecast to 2020
4.4.1 Europe Sales (Consumption), Production, Import and Export of Antihypertensive Drugs 2015 to 2020
4.5 Japan Market Forecast to 2020
4.5.1 Japan Sales (Consumption), Production, Import and Export of Antihypertensive Drugs 2015 to 2020
4.6 India Market Forecast to 2020
4.6.1 India Sales (Consumption), Production, Import and Export of Antihypertensive Drugs 2015 to 2020
4.8 China Market Forecast to 2020
4.8.1 China Sales (Consumption), Production, Import and Export of Antihypertensive Drugs 2015 to 2020
5 Applications
5.1 Applications in Different kinds of Hypertension
5.1.1 Primary Hypertension
5.1.2 Secondary Hypertension
5.2 Applications in Different Populations
5.2.1 Adults
5.2.2 Aged population
5.2.3 Children
5.2.4 Pregnant Women
5.1 Applications and Price Scope Interviewed in Major Applications
5.2 Applications and Price Scope Interviewed in Different kinds of Hypertension and Population
5.2.1 Price Scope (Interviewed Price to Buyers) of Antihypertensive Drugs 2015 and 2016
5.2.2 Consumption and Forecast of Antihypertensive Drugs 2015 to 2020
5.2.2 Consumption Growth Rate Forecast of Antihypertensive Drugs in Different kinds of Hypertension and Population 2015 to 2020
5.3.3 Consumption Market Share of Antihypertensive Drugs in Different kinds of Hypertension and Population 2015 to 2020
5.3 Primary Hypertension
5.3.1 Primary Hypertension Analysis
5.3.2 Key Consumers (Buyers) and Contact of Antihypertensive Drugs in Primary Hypertension
5.4 Secondary Hypertension
5.4.1 Secondary Hypertension Analysis
5.4.2 Key Consumers (Buyers) and Contact of Antihypertensive Drugs in Secondary Hypertension
6 Key Manufacturers Analysis of Antihypertensive Drugs
6.1 Pfizer
6.1.1 Company Basic Information
6.1.2 Antihypertensive Drugs Product Segment of Pfizer
6.1.2.1 Norvasc and Price in 2015 and 2016
6.1.3 Antihypertensive Drugs Sales, Revenue, Price of Pfizer 2015 to 2016
6.1.4 Interviewee, Name and Contact
6.2 Norvatis
6.2.1 Company Basic Information
6.2.2 Antihypertensive Drugs Product Segment of Norvatis
6.2.2.1 Diovan and Price in 2015 and 2016
6.2.2.2 Lotensin and Price in 2015 and 2016
6.2.2.3 Tekturna and Price in 2015 and 2016
6.2.3 Antihypertensive Drugs Sales, Revenue, Price of Norvatis 2015 to 2016
6.2.4 Interviewee, Name and Contact
6.3 Merck
6.3.1 Company Basic Information
6.3.2 Antihypertensive Drugs Product Segment of Merck
6.3.2.1 COZAAR and Price in 2015 and 2016
6.3.2.2 HYZAAR and Price in 2015 and 2016
6.3.2.3 PRINIVIL and Price in 2015 and 2016
6.3.3 Antihypertensive Drugs Sales, Revenue, Price of Merck 2015 to 2016
6.3.4 Interviewee, Name and Contact
6.4 Sanofi
6.4.1 Company Basic Information
6.4.2 Antihypertensive Drugs Product Segment of Sanofi
6.4.2.1 Aprovel and Price in 2015 and 2016
6.4.2.2 Ramipril and Price in 2015 and 2016
6.4.3 Antihypertensive Drugs Sales, Revenue, Price of Sanofi 2015 to 2016
6.4.4 Interviewee, Name and Contact
6.5 Daiichi-Sankyo
6.5.1 Company Basic Information
6.5.2 Antihypertensive Drugs Product Segment of Daiichi-Sankyo
6.5.2.1 Benicar / Benicar HCT and Price in 2015 and 2016
6.5.2.2 Azor and Price in 2015 and 2016
6.5.2.3 Tribenzor and Price in 2015 and 2016
6.5.3 Antihypertensive Drugs Sales, Revenue, Price of Daiichi-Sankyo 2015 to 2016
6.5.4 Interviewee, Name and Contact
6.6 Boehringer-Ingelheim
6.6.1 Company Basic Information
6.6.2 Antihypertensive Drugs Product Segment of Boehringer-Ingelheim by Type
6.6.2.1 Micardis and Price in 2015 and 2016
6.6.2.2 Micartis HCT and Price in 2015 and 2016
6.6.3 Antihypertensive Drugs Sales, Revenue, Price of Boehringer-Ingelheim 2015 to 2016
6.6.4 Interviewee, Name and Contact
6.7 Bayer
6.7.1 Company Basic Information
6.7.2 Antihypertensive Drugs Product Segment of Bayer by Type
6.7.2.1 Adempas and Price in 2015 and 2016
6.7.2.2 Adalat GITS and Price in 2015 and 2016
6.7.3 Antihypertensive Drugs Sales, Revenue, Price of Bayer 2015 to 2016
6.7.4 Interviewee, Name and Contact
6.8 AstraZeneca
6.8.1 Company Basic Information
6.8.2 Antihypertensive Drugs Product Segment of AstraZeneca
6.8.2.1 Atacand, Atacand HCT, Atacand Plus and Price in 2015 and 2016
6.8.2.2 Seloken ZOK, Toprol-XL, Betaloc ZOK and Price in 2015 and 2016
6.8.2.3 Tenormin, Tenormine, Prenormine, Atenol and Price in 2015 and 2016
6.8.2.4 Zestril and Price in 2015 and 2016
6.8.3 Antihypertensive Drugs Sales, Revenue, Price of AstraZeneca 2015 to 2016
6.8.4 Interviewee, Name and Contact
6.9 GSK
6.9.1 Company Basic Information
6.9.2 Antihypertensive Drugs Product Segment of GSK by Type
6.9.2.1 Lacipil and Price in 2015 and 2016
6.9.2.2 Coreg and Price in 2015 and 2016
6.9.3 Antihypertensive Drugs Sales, Revenue, Price of GSK 2015 to 2016
6.9.4 Interviewee, Name and Contact
6.10 Bristol-Myers Squibb
6.10.1 Company Basic Information
6.10.2 Antihypertensive Drugs Product Segment of Bristol-Myers Squibb by Type
6.10.2.1 COVERAM and Price in 2015 and 2016
6.10.2.2 Triplixam and Price in 2015 and 2016
6.10.2.3 Natrilix SR and Price in 2015 and 2016
6.10.3 Antihypertensive Drugs Sales, Revenue, Price of Bristol-Myers Squibb 2015 to 2016
6.10.4 Interviewee, Name and Contact
6.11 Tekeda
6.11.1 Company Basic Information
6.11.2 Antihypertensive Drugs Product Segment of Tekeda by Type
6.11.2.2 Edarbyclor and Price in 2015 and 2016
6.11.3 Antihypertensive Drugs Sales, Revenue, Price of Tekeda 2015 to 2016
6.11.4 Interviewee, Name and Contact
6.12 Shihuida Pharm (China)
6.12.1 Company Basic Information
6.12.2 Antihypertensive Drugs Product Segment of Shihuida Pharm
6.12.2.2 Yatan and Price in 2015 and 2016
6.12.3 Antihypertensive Drugs Sales, Revenue, Price of Shihuida Pharm 2015 to 2016
6.13 Second Pharmaceutical (China)
6.13.1 Company Basic Information
6.13.2 Antihypertensive Drugs Product Segment of Second Pharmaceutical
6.13.2.2 Suiyue and Price in 2015 and 2016
6.13.3 Antihypertensive Drugs Sales, Revenue, Price of Second Pharmaceutical 2015 to 2016
6.14 Yangtze River Pharmaceutical(China)
6.14.1 Company Basic Information
6.14.2 Antihypertensive Drugs Product Segment of Yangtze River Pharmaceutical
6.14.2.2 Suining and Price in 2015 and 2016
6.14.2.4 Landi and Price in 2015 and 2016
6.14.2.6 Yisu and Price in 2015 and 2016
6.14.2.7 Xingdi and Price in 2015 and 2016
6.14.3 Antihypertensive Drugs Sales, Revenue, Price of Yangtze River Pharmaceutical 2015 to 2016
6.15 Hengrui Medicine (China)
6.15.1 Company Basic Information
6.15.2 Antihypertensive Drugs Product Segment of Hengrui Medicine
6.15.2.2 Enalapril Maleate Tablets and Price in 2015 and 2016
6.15.3 Antihypertensive Drugs Sales, Revenue, Price of Hengrui Medicine 2015 to 2016
6.16 Qilu Pharmaceutical (China)
6.16.1 Company Basic Information
6.16.2 Antihypertensive Drugs Product Segment of Qilu Pharmaceutical
6.16.3 Antihypertensive Drugs Sales, Revenue, Price of Qilu Pharmaceutical 2015 to 2016
6.17 HUALON (China)
6.17.1 Company Basic Information
6.17.2 Antihypertensive Drugs Product Segment of HUALON
6.17.3 Antihypertensive Drugs Sales, Revenue, Price of HUALON 2015 to 2016
6.18 Dawnrays (China)
6.18.1 Company Basic Information
6.18.2 Antihypertensive Drugs Product Segment of Dawnrays
6.18.3 Antihypertensive Drugs Sales, Revenue, Price of Dawnrays 2015 to 2016
6.19 HISUN Pharmceutical (China)
6.19.1 Company Basic Information
6.19.2 Antihypertensive Drugs Product Segment of HISUN Pharmceutical
6.19.3 Antihypertensive Drugs Sales, Revenue, Price of HISUN Pharmceutical 2015 to 2016
7 Technology Development Trend
7.1 Manufacturing Process of Antihypertensive Drugs
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 Research Findings and Conclusion
Figure Picture of Antihypertensive Drugs
Figure Global Market Size (Value) of Antihypertensive Drugs 2015-2020
Figure Global Market Size (Volume) of Antihypertensive Drugs 2015-2020
Figure China Market Size (Value) of Antihypertensive Drugs 2015-2020
Figure China Market Size (Volume) of Antihypertensive Drugs 2015-2020
Table Market Share of Each Type
Figure Growth Rate of Each Type 2015 to 2016
Table Price List (Interviewed) of Type 1 by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of ARB by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of ARB by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of ACE-I by Key Manufacturers in 2015 and 2016
Table Global Market Antihypertensive Drugs Sales List of Key Manufacturers 2015 to 2016
Table Global Market Antihypertensive Drugs Sales Share List of Key Manufacturers 2015 to 2016
Table Global Market Antihypertensive Drugs Revenue List of Key Manufacturers 2015 to 2016
Table Global Market Antihypertensive Drugs Revenue Share List of Key Manufacturers 2015 to 2016
Table Global Antihypertensive Drugs Average Price List of Key Manufacturers 2015 to 2016
Table China Market Antihypertensive Drugs Sales List of Key Manufacturers 2015 to 2016
Table China Market Antihypertensive Drugs Sales Share List of Key Manufacturers 2015 to 2016
Table China Market Antihypertensive Drugs Revenue List of Key Manufacturers 2015 to 2016
Table China Market Antihypertensive Drugs Revenue Share List of Key Manufacturers 2015 to 2016
Table China Antihypertensive Drugs Average Price List of Key Manufacturers 2015 to 2016
Table Global Sales of Each Type 2015 to 2016
Table Global Sales Market Share of Each Type 2015 to 2016
Table Global Revenue of Each Type 2015 to 2016
Table Global Revenue Market Share of Each Type 2015 to 2016
Figure CCB Sales and Growth Rate 2015 to 2020
Figure ACE-I Sales and Growth Rate 2015 to 2020
Figure ARB Sales and Growth Rate 2015 to 2020
Figure Adrenergic Receptor Antagonists Sales and Growth Rate 2015 to 2020
Figure ARB Sales and Growth Rate 2015 to 2020
Table Sales and Forecast of Antihypertensive Drugs by Regions 2015-2020
Figure Sales Growth Rate Forecast of Antihypertensive Drugs by Regions 2015 to 2020
Table Production and Forecast of Antihypertensive Drugs by Regions 2015 to 2020
Figure Production Growth Rate Forecast of Antihypertensive Drugs by Regions 2015 to 2020
Table North America Sales, Production, Import and Export of Antihypertensive Drugs 2015 to 2020
Table Europe Sales, Production, Import and Export of Antihypertensive Drugs 2015 to 2020
Table Japan Sales, Production, Import and Export of Antihypertensive Drugs 2015 to 2020
Table India Sales, Production, Import and Export of Antihypertensive Drugs 2015 to 2020
Table China Sales, Production, Import and Export of Antihypertensive Drugs 2015 to 2020
Table Price Scope (Interviewed Price to Buyers) of Antihypertensive Drugs in Major Applications 2015 and 2016
Table Consumption and Forecast of Antihypertensive Drugs in Major Applications 2015 to 2020
Table Consumption Growth Rate Forecast of Antihypertensive Drugs in Major Applications 2015 to 2020
Table Consumption Market Share of Antihypertensive Drugs in Major Applications 2015 to 2020
Table Key Consumers (Buyers) and Contact of Antihypertensive Drugs in Application 1
Table Key Consumers (Buyers) and Contact of Antihypertensive Drugs in Secondary Hypertension
Table Pfizer Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Pfizer 2015 to 2016
Table Norvatis Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Norvatis 2015 to 2016
Table Merck Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Merck 2015 to 2016
Table Sanofi Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Sanofi 2015 to 2016
Table Daiichi-Sankyo Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Daiichi-Sankyo 2015 to 2016
Table Boehringer-Ingelheim Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Boehringer-Ingelheim 2015 to 2016
Table Bayer Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Bayer 2015 to 2016
Table AstraZeneca Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of AstraZeneca 2015 to 2016
Table GSK Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of GSK 2015 to 2016
Table Bristol-Myers Squibb Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Bristol-Myers Squibb 2015 to 2016
Table Tekeda Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Tekeda 2015 to 2016
Table Shihuida Pharm Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Shihuida Pharm 2015 to 2016
Table Second Pharmaceutical Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Second Pharmaceutical 2015 to 2016
Table Yangtze River Pharmaceutical Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Second Pharmaceutical 2015 to 2016
Table Hengrui Medicine Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Second Pharmaceutical 2015 to 2016
Table Qilu Pharmaceutical Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Second Pharmaceutical 2015 to 2016
Table HUALON Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of HUALON 2015 to 2016
Table Dawnrays Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Second Pharmaceutical 2015 to 2016
Table HISUN Pharmceutical Basic Information List
Table Antihypertensive Drugs Sales, Revenue, Price of Second Pharmaceutical 2015 to 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
